Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents
Project Number2R44ES034319-02
Former Number1R43ES034319-01
Contact PI/Project LeaderBOXLEY, CHETT J
Awardee OrganizationGLYCOSURF, INC.
Description
Abstract Text
Project Summary
Ambient air pollution significantly contributes to the global disease burden, leading to increased morbidity and
mortality. In 2019, particulate air pollution alone contributed to over 4 million premature deaths. Mineral dusts, a
component of atmospheric particulate matter, affect global biogeochemical cycles, pollute water bodies and air
masses, and impact global climate. Dust poses both physical and health hazards, the latter particularly affecting
cardiovascular and respiratory health. Mining activities generate dust at various stages, including excavation,
blasting, stockpiling, crushing, grinding, and transport. Dust from mining operations, both modern and legacy,
serves as an exposure route for other contaminants like arsenic and lead. To safeguard human and
environmental health from mining-related dust, innovative and environmentally compatible technologies are
essential to mitigate dust emissions. Research in Phase I demonstrated that glycolipid surfactants are effective
dust suppressants, matching or surpassing currently available products. Despite the availability of various dust
suppression products, market opportunities exist for new technologies to address their disadvantages, such as
corrosiveness to machinery, potential risks to human health from hazardous components, and short-term
effectiveness due to susceptibility to disruption by environmental factors like strong winds. The overarching
goal of this Phase II SBIR is to demonstrate the commercial potential of a next-generation green dust
suppression technology using GlycoSurf’s proprietary glycolipid surfactants. This will be achieved through field
testing on an active mining site, expanding the physicochemical diversity of tailings evaluated, and elucidating
the fundamental materials science and engineering principles driving glycolipid dust suppression efficacy. The
Phase II project has four aims. Aim 1 will refine and scale-up glycolipid synthesis to produce kilogram quantities
of glycolipids. Aim 2 will establish a field test site on an active mine operation to perform two studies designed
first to screen glycolipids for best performance and second, to study application frequency and concentration of
the best glycolipid formulation. Aim 3 will focus on analysis of the material properties of glycolipids and glycolipid-
mine tailing interactions to understand their correlation with dust suppression effectiveness, covering a range of
mine tailings geochemistry from both field and laboratory settings. Aim 4 will involve a technological and
economic assessment to determine the feasibility and commercial potential of scaling up and commercializing
glycolipid dust suppressant technology. Successful completion of this project will yield at least one candidate
formulation suitable for commercialization as a dust suppressant for mine tailings. These formulations will be
environmentally compatible and effective in reducing dust emissions, thus mitigating risks to human and
environmental health. The characterization of glycolipid performance will provide fundamental knowledge of
glycolipid structure-function relationships, guiding future development and driving innovation in green dust
suppressant technologies.
Public Health Relevance Statement
Project Narrative
Ambient air pollution is a leading contributor to global disease burden that increases morbidity and mortality,
and the mining industry accounts for 12% of global particulate matter health impacts. GlycoSurf and the
University of Arizona will field-test a novel technology using green environmentally-friendly glycolipid
surfactants for the suppression of tailings dusts at an operational mine. Successful application of this
technology will reduce emissions from mining operations that impact surrounding communities and
environment and thereby protect human and environmental health risks from the mining industry.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAffectAgricultureAirAir PollutionAridityArizonaArsenicAtmosphereAutomobile DrivingCementationCessation of lifeChemicalsChemistryClimateCollaborationsCommunitiesCorrosivesDevelopmentDiameterDisadvantagedDustEffectivenessElementsEngineeringEnvironmentEnvironmental HealthEnvironmental Risk FactorEvaluationFeasibility StudiesFormulationFrequenciesFriendsFutureGlycolipidsGoalsHealthHealth HazardsHumanIndustryInhalationKilogramKnowledgeLaboratoriesLeadMarketingMiningModernizationMorbidity - disease rateMorphologyOutcomeParticle SizeParticulateParticulate MatterPerformancePhasePredispositionProcessProductionPropertyProtocols documentationReapplicationRegulationResearchResearch DesignRiskSamplingSiteSmall Business Innovation Research GrantStructure-Activity RelationshipTailTechnologyTechnology AssessmentTestingToxic effectTransportationUniversitiesWaterWater PollutionWeatherambient air pollutionburden of illnesscardiovascular healthclimate changecoarse particlescommercializationcosteconomic evaluationexposure routefield studyfine particlesgeochemistryglobal healthimprovedindexinginnovationinsightmaterials sciencemeetingsmetermineral dustmortalitynew technologynext generationoperationparticleprematureprocess improvementresearch and developmentrespiratory healthrisk mitigationscale upsurfactantwasting
National Institute of Environmental Health Sciences
CFDA Code
143
DUNS Number
079763857
UEI
J7RUJJ2WHZF8
Project Start Date
24-May-2022
Project End Date
30-November-2026
Budget Start Date
20-December-2024
Budget End Date
30-November-2025
Project Funding Information for 2025
Total Funding
$511,412
Direct Costs
$428,720
Indirect Costs
$49,235
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Environmental Health Sciences
$511,412
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R44ES034319-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R44ES034319-02
Patents
No Patents information available for 2R44ES034319-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R44ES034319-02
Clinical Studies
No Clinical Studies information available for 2R44ES034319-02
News and More
Related News Releases
No news release information available for 2R44ES034319-02
History
No Historical information available for 2R44ES034319-02
Similar Projects
No Similar Projects information available for 2R44ES034319-02